Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis

被引:29
|
作者
Vollenberg, Richard [1 ]
Tepasse, Phil-Robin [1 ]
Ochs, Kevin [1 ]
Floer, Martin [2 ]
Strauss, Markus [3 ]
Rennebaum, Florian [1 ]
Kabar, Iyad [1 ]
Rovas, Alexandros [4 ]
Nowacki, Tobias [1 ,5 ]
机构
[1] Univ Hosp Muenster, Dept Med B Gastroenterol Hepatol Endocrinol & Cli, D-48149 Munster, Germany
[2] Klinikum Ibbenburen, Dept Med 1, D-49477 Ibbenburen, Germany
[3] Univ Hosp Muenster, Dept Cardiol Coronary I Peripheral Vasc Dis Heart, D-48149 Munster, Germany
[4] Univ Hosp Muenster, Dept Med D, Div Gen Internal & Emergency Med Nephrol & Rheuma, D-48149 Munster, Germany
[5] Marienhosp Steinfurt, Dept Med Gastroenterol, D-48565 Steinfurt, Germany
来源
VIRUSES-BASEL | 2021年 / 13卷 / 11期
关键词
SARS-CoV-2; COVID-19; syndecan-1; glycocalyx; long-COVID-19; INFECTION;
D O I
10.3390/v13112324
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The COVID-19 pandemic is caused by the SARS CoV-2 virus and can lead to severe lung damage and hyperinflammation. In the context of COVID-19 infection, inflammation-induced degradation of the glycocalyx layer in endothelial cells has been demonstrated. Syndecan-1 (SDC-1) is an established parameter for measuring glycocalyx injury. This prospective, multicenter, observational, cross-sectional study analyzed SDC-1 levels in 24 convalescent patients that had been infected with SARS-CoV-2 with mild disease course without need of hospitalization. We included 13 age-matched healthy individuals and 10 age-matched hospitalized COVID-19 patients with acute mild disease course as controls. In convalescent COVID-19 patients, significantly elevated SDC-1 levels were detected after a median of 88 days after symptom onset compared to healthy controls, whereas no difference was found when compared to SDC-1 levels of hospitalized patients undergoing acute disease. This study is the first to demonstrate signs of endothelial damage in non-pre-diseased, convalescent COVID-19 patients after mild disease progression without hospitalization. The data are consistent with studies showing evidence of persistent endothelial damage after severe or critical disease progression. Further work to investigate endothelial damage in convalescent COVID-19 patients should follow.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Characterization of Headache in COVID-19: a Retrospective Multicenter Study
    dos Anjos de Paula, Rafael Cesar
    de Maria Frota Vasconcelos, Thais
    da Costa, Francisco Bruno Santana
    de Brito, Lara Albuquerque
    Torres, Danielle Mesquita
    Moura, Alissa Elen Formiga
    Oliveira, Danilo Nunes
    de Lima Henn, Guilherme Alves
    Rodrigues, Pedro Gustavo Barros
    de Sousa Pereira, Isabelle
    Braga, Ianna Lacerda Sampaio
    Rocha, Felipe Araujo
    Frota, Norberto Anizio Ferreira
    Carvalho, Fernanda Martins Maia
    Pitombeira, Milena Sales
    Tavares-Junior, Jose Wagner Leonel
    Montenegro, Raquel Carvalho
    Braga-Neto, Pedro
    Nobrega, Paulo Ribeiro
    Sobreira-Neto, Manoel Alves
    MOLECULAR NEUROBIOLOGY, 2021, 58 (9) : 4487 - 4494
  • [42] Intracranial compliance in patients with COVID-19: a multicenter observational study
    Silveira, Ana Flavia
    Santos, Marcella Barreto
    Collange, Nelci Zanon
    Hayashi, Cintya Yukie
    Vilela, Gustavo Henrique Frigieri
    de Almeida, Samantha Longhi Simoes
    de Andrade, Joao Brainer Clares
    Rojas, Salomon
    de Moraes, Fabiano Moulin
    Veiga, Viviane Cordeiro
    Flato, Uri Adrian Prync
    Russo, Thiago Luiz
    Silva, Gisele Sampaio
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2024, 82 (09) : 1 - 8
  • [43] The impact of COVID-19 in patients with psoriasis: A multicenter study in Istanbul
    Kara Polat, Asude
    Oguz Topal, Ilteris
    Karadag, Ayse Serap
    Aksoy, Hasan
    Koku Aksu, Ayse Esra
    Ozkur, Ezgi
    Ozkok Akbulut, Tugba
    Topaloglu Demir, Filiz
    Engin, Burhan
    Uzuncakmak, Tugba Kevser
    Kivanc Altunay, Ilknur
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [44] Immune memory in convalescent patients with asymptomatic or mild COVID-19
    Long, Quan-Xin
    Jia, Yan-Jun
    Wang, Xin
    Deng, Hai-Jun
    Cao, Xiao-Xia
    Yuan, Jun
    Fang, Liang
    Cheng, Xu-Rong
    Luo, Chao
    He, An-Ran
    Tang, Xiao-Jun
    Hu, Jie-li
    Hu, Yuan
    Tang, Ni
    Cai, Xue-Fei
    Wang, De-Qiang
    Hu, Jie
    Qiu, Jing-Fu
    Liu, Bei-Zhong
    Chen, Juan
    Huang, Ai-long
    CELL DISCOVERY, 2021, 7 (01)
  • [45] Treatment with convalescent plasma for COVID-19 patients in Wuhan, China
    Ye, Mingxiang
    Fu, Dian
    Ren, Yi
    Wang, Faxiang
    Wang, Dong
    Zhang, Fang
    Xia, Xinyi
    Lv, Tangfeng
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 1890 - 1901
  • [46] COVID-19 Secondary Infections in ICU Patients and Prevention Control Measures: A Preliminary Prospective Multicenter Study
    Ruiz-Santana, Sergio
    Mora-Quintero, Maria-Luisa
    Saavedra, Pedro
    Montiel-Gonzalez, Raquel
    Sanchez-Ramirez, Catalina
    Perez-Acosta, Guillermo
    Martin-Velasco, Mar
    Rodriguez-Mata, Cristobal
    Lorenzo-Garcia, Jose-Manuel
    Parrilla-Toribio, Dacil
    Carrillo-Garcia, Tanya
    Martin-Gonzalez, Juan-Carlos
    ANTIBIOTICS-BASEL, 2022, 11 (08):
  • [47] Convalescent plasma: A potential therapeutic option for COVID-19 patients
    Ng, Swee
    Soon, Tsuey
    Yap, Wei
    Liew, Kai
    Lim, Ya
    Ming, Long
    Tang, Yin-Quan
    Goh, Bey
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2020, 13 (11) : 477 - 486
  • [48] Persistent Critical Illness and Long-Term Outcomes in Patients With COVID-19: A Multicenter Retrospective Cohort Study
    Ling, Ryan Ruiyang
    Bonavia, William
    Reddy, Mallikarjuna Ponnapa
    Pilcher, David
    Subramaniam, Ashwin
    CRITICAL CARE EXPLORATIONS, 2024, 6 (03) : E1057
  • [49] Efficacy of convalescent plasma therapy in severe COVID-19 patients
    Cizmecioglu, Hilal Akay
    Goktepe, Mevlut Hakan
    Demircioglu, Sinan
    Tekinalp, Atakan
    Cizmecioglu, Ahmet
    Tuna, Ali Kursat
    Ozer, Huseyin
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (04)
  • [50] Convalescent Plasma in COVID-19 Patients. Hope Fades
    Cristians Auza-Santivanez, Jhossmar
    Pablo Jaldin-Vasquez, Juan
    Salazar Duany, Zuzel
    Sanchez Escalante, Carlos
    Mariano Tecualt-Gomez, Luis
    Martinez Larrarte, Jose Pedro
    REVISTA CUBANA DE REUMATOLOGIA, 2021, 23 (01):